{
    "2014-05-14": [
        "PFE - Tuesday’s Top Health Care Stories: Halozyme, Insys, Pfizer, and Astr...",
        "Surely biggest Q re PFE commitments to UK is, what is consequence if further M&A occurs within 5yrs? A high likelihood...",
        "Soriot asked why PFE's price (4x sales) does not reflect company's value - cites price paid by NVS for GSK's oncology unit...",
        "PFE CEO: AstraZeneca drugs warning ‘red herring’"
    ]
}